Zhongde Wang Selected Research

Zhongde Wang Research Topics

Disease

18	Infections 10/2023 - 02/2004
10	Vaccinia 08/2010 - 04/2003
9	Neoplasms (Cancer) 01/2022 - 03/2003
8	COVID-19 01/2023 - 09/2020
6	Virus Diseases (Viral Diseases) 02/2022 - 02/2004
3	Zika Virus Infection 01/2019 - 01/2017
3	Communicable Diseases (Infectious Diseases) 04/2009 - 11/2002
2	Severe Acute Respiratory Syndrome 01/2023 - 01/2021
2	Bovine Mastitis 05/2019 - 01/2019
2	Human Influenza (Influenza) 01/2019 - 11/2017
2	Adenoviridae Infections (Adenovirus Infections) 01/2018 - 08/2015
1	Disease Progression 01/2023
1	Inflammation (Inflammations) 01/2023
1	Viral Pneumonia 01/2023
1	Yellow Fever 01/2021
1	Weight Loss (Weight Reduction) 10/2020
1	Mastitis 01/2019
1	Hantavirus Infections 11/2018
1	Inborn Genetic Diseases (Disease, Hereditary) 10/2018
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2018
1	Atrophy 10/2017
1	Severe Fever with Thrombocytopenia Syndrome 02/2017
1	Ovarian Neoplasms (Ovarian Cancer) 04/2016
1	Herpes Simplex 01/2014
1	Viremia 04/2006
1	Cytomegalovirus Infections (Inclusion Disease) 02/2004
1	Sarcoma (Soft Tissue Sarcoma) 03/2003
1	Tetanus 11/2002

Drug/Important Bio-Agent (IBA)

19	VaccinesIBA 02/2022 - 11/2002
9	AntigensIBA 01/2021 - 04/2004
8	Proteins (Proteins, Gene)FDA Link 01/2019 - 04/2003
7	Antiviral Agents (Antivirals)IBA 02/2022 - 01/2017
4	Monoclonal AntibodiesIBA 02/2022 - 10/2020
3	N-(2-cyanoethylene)urea (BA 1)IBA 10/2023 - 01/2022
3	N-methyl-valyl-amiclenomycin (BA 2)IBA 01/2023 - 01/2022
3	AntibodiesIBA 01/2019 - 10/2017
3	Neutralizing AntibodiesIBA 01/2018 - 04/2004
3	EpitopesIBA 02/2004 - 11/2002
2	Angiotensin-Converting Enzyme 2IBA 01/2023 - 01/2022
2	molnupiravirIBA 02/2022 - 01/2022
2	COV2-2196IBA 02/2022 - 01/2022
2	COV2-2130IBA 02/2022 - 01/2022
2	nirmatrelvirIBA 02/2022 - 01/2022
2	Complement System Proteins (Complement)IBA 01/2022 - 01/2021
2	InterferonsIBA 11/2020 - 08/2015
2	Glycoproteins (Glycoprotein)IBA 01/2020 - 04/2004
2	favipiravirIBA 11/2017 - 02/2017
2	Interferon Type IIBA 11/2017 - 08/2015
2	Subunit VaccinesIBA 03/2011 - 03/2006
2	HLA-A*02:01 antigenIBA 10/2008 - 11/2002
2	PhosphoproteinsIBA 02/2005 - 08/2004
2	HLA Antigens (Human Leukocyte Antigens)IBA 02/2005 - 11/2002
2	Peptides (Polypeptides)IBA 02/2004 - 11/2002
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	FluorineIBA 01/2023
1	K-18 conjugate (K18)IBA 01/2022
1	SAB-185IBA 07/2021
1	Viral RNAIBA 10/2020
1	IronIBA 01/2020
1	Phospholipases A2 (Phospholipase A2)IBA 05/2019
1	Hemagglutinins (Hemagglutinin)IBA 01/2019
1	Genetic Markers (Genetic Marker)IBA 01/2019
1	AerosolsIBA 11/2018
1	Matrix Metalloproteinases (MMPs)IBA 04/2016
1	nitidineIBA 04/2016
1	Thymidine KinaseIBA 01/2014
1	hippuryl-glycyl-glycine (HIGG)IBA 01/2013
1	Immunoglobulin G (IgG)IBA 01/2013
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 07/2011
1	Intergenic DNA (Junk DNA)IBA 08/2010
1	DNA (Deoxyribonucleic Acid)IBA 08/2010
1	Mamu-A 01 antigenIBA 04/2009
1	Indicators and Reagents (Reagents)IBA 08/2007
1	MVA vaccineIBA 08/2007
1	Peptide LibraryIBA 08/2007
1	OligodeoxyribonucleotidesIBA 04/2006
1	Immunodominant EpitopesIBA 08/2004
1	UbiquitinIBA 08/2004
1	HLA-B*07 antigenIBA 04/2003
1	Therapeutic UsesIBA 03/2003

Therapy/Procedure

8	Therapeutics 01/2022 - 04/2006
3	Immunotherapy 01/2019 - 03/2003
1	Precision Medicine 10/2018
1	Subcutaneous Injections 01/2017
1	Hematopoietic Stem Cell Transplantation 04/2006
1	Cell Transplantation 11/2002